Trial Profile
A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Safety Study of Pulmonary Function in Patients with Reduced Lung Function Treated with BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for Focal Upper Limb Spasticity Due to Upper Motor Neuron Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions
- Sponsors Allergan
- 26 May 2011 New trial record